Hi, what are you looking for?
Here are the biggest movers of the day:
Stock gainers:
Coherus BioSciences stock
CHRS,
rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal cancer when combined with chemotherapy that it makes with Shanghai Junshi Biosciences.
Read the full article here
This article was written by Follow Charles Rotblut, CFA is the editor of the AAII Journal, the flagship publication of The American Association of...
Watch full video on YouTube
This article was written by Follow Some tickers are covered more than others on the site, so with The Undercovered Dozen our Editors highlight...
Watch full video on YouTube
